Drugs / Petrolatum
Petrolatum
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03561376 | Sep 2021 → Sep 2026 expected | — | Melissa Pugliano-Mauro | Recruiting | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT03095872 | Mar 2017 → Jan 2018 | — | RWTH Aachen University | Completed | No outcome recorded |
| Phase 3 | NCT02109718 | Jan 2009 → Jul 2010 | — | University of the Philippines | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT07531472 | May 2026 → Apr 2028 expected | — | Assiut University | Not yet recruiting | No outcome recorded |
| — | NCT02338076 | Jun 2013 → Feb 2015 | skin disorder | Rockefeller University | Completed | No outcome recorded |
| — | NCT01315951 | Mar 2011 → Feb 2012 | seborrheic dermatitis | Ascension Health | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01984775 Comparator | Oct 2013 → Jul 2014 | psoriasis | Stiefel, a GSK Company | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07511192 Comparator | May 2026 → May 2027 expected | — | Assiut University | Not yet recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05553392 Comparator | Nov 2022 → May 2024 | radiodermatitis | Stratpharma AG | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | petrolatum | “Aquaphor contains 41 percent petrolatum (or petroleum jelly), the active ingredient, temporarily protects minor cuts, scrapes, and burns; protects and helps relieve chapped or...” NCT05553392 ↗5“Petrolatum is considered a skin protectant and has a strong ability to hold moisture in skin.” NCT01315951 ↗ “Negative control contains petrolatum.” NCT01984775 ↗ |
| Known as | Petroleum jelly | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07531472 ↗ |
| Known as | Vaseline | “Petroleum jelly (Vaseline) is widely used as a topical agent to maintain hydration, protect the mucosa, and reduce crust formation” NCT07511192 ↗2“The control, standard of care petrolatum (i.e. Vaseline) will be applied to the side indicated by "V"” NCT03561376 ↗ |
| Route | Topical | “then apply petroleum jelly to the area before bedtime” NCT01315951 ↗ |